Title of article
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth
Author/Authors
Zhou، نويسنده , , Bisheng and Ma، نويسنده , , Ruihua and Si، نويسنده , , Wenxia and Li، نويسنده , , Sisi and Xu، نويسنده , , Yan and Tu، نويسنده , , Xin and Wang، نويسنده , , Qing، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2013
Pages
11
From page
159
To page
169
Abstract
FGF2 and VEGFA are the two most potent angiogenic factors. Here we report that miR-503 can simultaneously down-regulate FGF2 and VEGFA. The expression of miR-503 is repressed in HCC cells and primary tumors due to a potential epigenetic mechanism. Overexpression of miR-503 reduced tumor angiogenesis in vitro and in vivo. We also found that miR-503 expression was down-regulated by hypoxia through HIF1α. These results identify a miRNA that targets both FGF2 and VEGFA in cancers, demonstrate the anti-angiogenesis role of miR-503 in tumorigenesis, and provide a novel mechanism for hypoxia-induced FGF2 and VEGFA through HIF1α-mediated inhibition of miR-503.
Keywords
Angiogenesis , miR-503 , FGF2 , Methylation , VEGFA
Journal title
Cancer Letters
Serial Year
2013
Journal title
Cancer Letters
Record number
1822740
Link To Document